Cargando…
Recent advances in understanding and managing cystic fibrosis transmembrane conductance regulator dysfunction
Cystic fibrosis is the most common autosomal recessive genetic disease in Caucasians and has been extensively studied for many decades. The cystic fibrosis transmembrane conductance regulator gene was identified in 1989. It encodes a complex protein which has numerous cellular functions. Our underst...
Autores principales: | Griesenbach, Uta, Alton, Eric W.F.W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Faculty of 1000 Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4447040/ https://www.ncbi.nlm.nih.gov/pubmed/26097737 http://dx.doi.org/10.12703/P7-64 |
Ejemplares similares
-
Cystic Fibrosis Gene Therapy in the UK and Elsewhere
por: Griesenbach, Uta, et al.
Publicado: (2015) -
Beta-defensin genomic copy number is not a modifier locus for cystic fibrosis
por: Hollox, Edward J, et al.
Publicado: (2005) -
Acquired cystic fibrosis transmembrane conductance regulator dysfunction
por: Banks, Catherine, et al.
Publicado: (2018) -
Taking stock of gene therapy for cystic fibrosis
por: Stern, Myra, et al.
Publicado: (2000) -
Barriers to and new approaches for gene therapy and gene delivery in cystic fibrosis
por: Ferrari, Stefano, et al.
Publicado: (2002)